Dievo Surgery Center
Dievo Surgery Center
Ukraine, Kyiv
Abu Shamsiya Rami Nuamanovych
27 anni di esperienza
Clinica certificata da :
The cost of immunotherapy with Keytruda (Pembrolizumab) in Ukraine generally ranges from $4,500 to $8,000. Prices vary depending on the clinic, the oncologist’s experience, the number of treatment cycles, and whether Keytruda is combined with other therapies. In the United States, the average cost is $21,500 (per NCCN). That means immunotherapy with Keytruda in Ukraine can be about 71% less than in the U.S.
Ukrainian clinics usually include the cost of the Keytruda drug, oncologist consultations, infusion sessions, basic pre-treatment bloodwork, and routine follow-ups. In the U.S., drug costs, infusion fees, and lab work are often billed separately. Always confirm if extra tests, imaging, or supportive medications are covered in your treatment package.
| Ukraine | Turchia | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | da $4,500 | da $3,300 | da $15,000 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Immunotherapy with Keytruda (Pembolizumab). Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Immunotherapy with Keytruda (Pembolizumab) al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Immunotherapy with Keytruda (Pembolizumab) e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Immunotherapy with Keytruda (Pembolizumab).
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
Dr. Abu Shamsiya Rami Nuamanovych is a specialist in general and laparoscopic surgery, oncology, and ultrasound diagnostics. He is a Candidate of Medical Sciences, an associate professor, and a doctor of the highest category. Dr. Nuamanovych is a member of the Ukrainian Association of Bariatric Surgeons and the World Organization of Bariatric Surgeons (IFSO).
He works as a WHO consultant on laparoscopic surgery. He is also President of the Association of Arab Doctors of Ukraine. Dr. Nuamanovych has performed thousands of surgeries, including hernia repairs, bariatric procedures, and cancer operations. His skills are recognized internationally. He speaks English and Arabic fluently.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.